| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |